BioLineRx Ltd.
BLRX · Healthcare · $10M
$2.36-2.88%
Price
$3.12
$2.43
Jun 30, 26Sep 28, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue$0M+19.5%
6/'26 vs prev quarter
Company Health
Market Cap$10M
Operating Margin-876.3%
Cash on Hand$13M131.1% of market cap
Among 326 Biotechnology peers
LowMedianHigh
PSR7.6xmedian 11.1xPBR0.8xmedian 2.0xROE-58.3%median -54.5%BioLineRx Ltd. (BLRX) Q2 2026 Earnings Call TranscriptAug 31
BioLineRx Reports Second Quarter 2026 Financial Results and Provides Corporate UpdateAug 31
BioLineRx Announces $3.75 Million Registered Direct Offering and Concurrent Private PlacementAug 28
BioLineRx to Report Second Quarter 2026 Results on August 31, 2026Aug 25
BioLineRx and Hemispherian AS to Present Data Demonstrating Strong Synergy of GLIX1 with PARP Inhibitors in HR-Proficient Ovarian Cancers at ESMO 2026Jul 20
BioLineRx and Hemispherian Announce New Preclinical Data Demonstrating Strong Synergistic Effect between GLIX1 and PARP Inhibitor in a Patient-Derived Ovarian Cancer Xenograft ModelJul 8
